APA (7th ed.) Citation

B, C., YT, H., & R, S. (2024). Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 30(4), 402. https://doi.org/10.1016/j.eprac.2023.11.014

Chicago Style (17th ed.) Citation

B, Cohen, Harris YT, and Schulman-Rosenbaum R. "Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 30, no. 4 (2024): 402. https://doi.org/10.1016/j.eprac.2023.11.014.

MLA (9th ed.) Citation

B, Cohen, et al. "Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 30, no. 4, 2024, p. 402, https://doi.org/10.1016/j.eprac.2023.11.014.